SPR Therapeutics announced eight scientific abstracts that will be presented at the upcoming ASRA Pain Medicine Meeting, including positive results for the RESET Clinical Trial’s Primary Endpoint, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback